Physician profile
Amanda S Holthouse
NPI 1962799700
$3,139.54
in general payments reported to CMS, 2019-2025
25 companies · $293 in 2025
The $293 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,888 · 2020: $66.61 · 2021: $199 · 2022: $84.16 · 2023: $267 · 2024: $343 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $882.85 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,698.84 | 2019 | |
| Abbvie INC. | $172.59 | 2021-2024 | |
| Astellas Pharma US INC | $150.14 | 2023-2024 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $114.68 | 2023-2025 | Myfembree |
| Pfizer INC. | $112.58 | 2022-2024 | |
| Organon LLC | $103.41 | 2021-2025 | Nexplanon, Jada System |
| Amag Pharmaceuticals, INC. | $84.06 | 2019 | |
| Abbott Laboratories | $80.72 | 2021 | |
| Mayne Pharma Commercial LLC | $80.54 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $61.24 | 2019-2020 | |
| Therapeuticsmd, INC. | $58.21 | 2019-2021 | |
| Shield Therapeutics INC | $57.27 | 2023-2024 | Accrufer |
| Ethicon US, LLC | $56.82 | 2020-2024 | Enseal X1, Dermabond Prineo |
| Dexcom, INC. | $54.75 | 2024-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $45.97 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $35.62 | 2025 | Visiclear |
| Minerva Surgical, INC | $23.54 | 2024 | |
| Convatec INC. | $22.91 | 2020 | |
| Lilly USA, LLC | $22.55 | 2025 | Zepbound |
| Coopersurgical, INC. | $19.38 | 2021 | |
| Avanos Medical | $18.75 | 2024 | On-Q* Pump and Accessories |
| Covidien LP | $17.63 | 2019 | |
| Allergan, INC. | $17.04 | 2019 | |
| Biogen, INC. | $15.98 | 2025 | Zurzuvae |
| Mylan Pharmaceuticals INC. | $14.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Holthouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.